U.S. flag

An official website of the United States government

NM_000249.4(MLH1):c.1783_1784del (p.Ser595fs) AND Colorectal cancer, hereditary nonpolyposis, type 2

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jul 24, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000018638.32

Allele description [Variation Report for NM_000249.4(MLH1):c.1783_1784del (p.Ser595fs)]

NM_000249.4(MLH1):c.1783_1784del (p.Ser595fs)

Gene:
MLH1:mutL homolog 1 [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000249.4(MLH1):c.1783_1784del (p.Ser595fs)
HGVS:
  • NC_000003.12:g.37047566AG[2]
  • NG_007109.2:g.59217AG[2]
  • NM_000249.4:c.1783_1784delMANE SELECT
  • NM_001167617.3:c.1489_1490del
  • NM_001167618.3:c.1060_1061del
  • NM_001167619.3:c.1060_1061del
  • NM_001258271.2:c.1783_1784del
  • NM_001258273.2:c.1060_1061del
  • NM_001258274.3:c.1060_1061del
  • NM_001354615.2:c.1060_1061del
  • NM_001354616.2:c.1060_1061del
  • NM_001354617.2:c.1060_1061del
  • NM_001354618.2:c.1060_1061del
  • NM_001354619.2:c.1060_1061del
  • NM_001354620.2:c.1489_1490del
  • NM_001354621.2:c.760_761del
  • NM_001354622.2:c.760_761del
  • NM_001354623.2:c.760_761del
  • NM_001354624.2:c.709_710del
  • NM_001354625.2:c.709_710del
  • NM_001354626.2:c.709_710del
  • NM_001354627.2:c.709_710del
  • NM_001354628.2:c.1783_1784del
  • NM_001354629.2:c.1684_1685del
  • NM_001354630.2:c.1732-951AG[2]
  • NP_000240.1:p.Ser595fs
  • NP_001161089.1:p.Ser497fs
  • NP_001161090.1:p.Ser354fs
  • NP_001161091.1:p.Ser354fs
  • NP_001245200.1:p.Ser595fs
  • NP_001245202.1:p.Ser354fs
  • NP_001245203.1:p.Ser354fs
  • NP_001341544.1:p.Ser354fs
  • NP_001341545.1:p.Ser354fs
  • NP_001341546.1:p.Ser354fs
  • NP_001341547.1:p.Ser354fs
  • NP_001341548.1:p.Ser354fs
  • NP_001341549.1:p.Ser497fs
  • NP_001341550.1:p.Ser254fs
  • NP_001341551.1:p.Ser254fs
  • NP_001341552.1:p.Ser254fs
  • NP_001341553.1:p.Ser237fs
  • NP_001341554.1:p.Ser237fs
  • NP_001341555.1:p.Ser237fs
  • NP_001341556.1:p.Ser237fs
  • NP_001341557.1:p.Ser595fs
  • NP_001341558.1:p.Ser562fs
  • LRG_216:g.59217AG[2]
  • NC_000003.11:g.37089057AG[2]
  • NC_000003.11:g.37089057_37089058del
  • NM_000249.3:c.1783_1784delAG
Protein change:
S237fs
Links:
LOVD 3: MLH1_001602; OMIM: 120436.0027; dbSNP: rs63750035
NCBI 1000 Genomes Browser:
rs63750035
Molecular consequence:
  • NM_000249.4:c.1783_1784del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001167617.3:c.1489_1490del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001167618.3:c.1060_1061del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001167619.3:c.1060_1061del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001258271.2:c.1783_1784del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001258273.2:c.1060_1061del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001258274.3:c.1060_1061del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354615.2:c.1060_1061del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354616.2:c.1060_1061del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354617.2:c.1060_1061del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354618.2:c.1060_1061del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354619.2:c.1060_1061del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354620.2:c.1489_1490del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354621.2:c.760_761del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354622.2:c.760_761del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354623.2:c.760_761del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354624.2:c.709_710del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354625.2:c.709_710del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354626.2:c.709_710del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354627.2:c.709_710del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354628.2:c.1783_1784del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354629.2:c.1684_1685del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354630.2:c.1732-951AG[2] - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Colorectal cancer, hereditary nonpolyposis, type 2 (LYNCH2)
Synonyms:
COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2; Lynch syndrome II; MLH1-Related Lynch Syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0012249; MedGen: C1333991; Orphanet: 144; OMIM: 609310

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002601715OMIM
no assertion criteria provided
Pathogenic
(Jun 1, 2007)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV004190028Myriad Genetics, Inc.
criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))
Pathogenic
(Jul 24, 2023)
unknownclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.

Poley JW, Wagner A, Hoogmans MM, Menko FH, Tops C, Kros JM, Reddingius RE, Meijers-Heijboer H, Kuipers EJ, Dinjens WN; Rotterdam Initiative on Gastrointestinal Hereditary Tumors..

Cancer. 2007 Jun 1;109(11):2349-56.

PubMed [citation]
PMID:
17440981

Details of each submission

From OMIM, SCV002601715.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a 4-year-old boy (case I) with glioblastoma, nephroblastoma, and cafe-au-lait spots consistent with mismatch repair cancer syndrome (MMRCS1; 276300), Poley et al. (2007) identified compound heterozygosity for 2 mutations in the MLH1 gene: a 2-bp deletion (593delAG) and a met35-to-asn (M35N; 120436.0028) substitution. Both tumors and normal tissue were negative for the MLH1 protein. The nephroblastoma showed microsatellite instability, but the glioblastoma did not. Both parents, who were each heterozygous for a respective mutation, came from families with HNPCC2 (LYNCH2; 609310).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Myriad Genetics, Inc., SCV004190028.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024